Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)
Information source: University of Cincinnati
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Sarcoidosis; Pulmonary Hypertension
Intervention: Observation (Other)
Phase: N/A
Status: Recruiting
Sponsored by: University of Cincinnati Official(s) and/or principal investigator(s): Robert P Baughman, MD, Study Chair, Affiliation: University of Cincinnati
Overall contact: Robert P Baughman, MD, Phone: 513-584-5225, Email: bob.baughman@uc.edu
Summary
Registry to follow patients with sarcoidosis associated pulmonary hypertension
Clinical Details
Official title: Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)
Study design: Observational Model: Case-Only, Time Perspective: Prospective
Primary outcome: Survival
Secondary outcome: Disease management
Detailed description:
This is a multi center registry of sarcoidosis associated pulmonary hypertension (SAPH).
With this registry, the investigators will characterize the demographics, clinical course,
hemodynamics, pulmonary physiology, and disease management of sarcoidosis associated
pulmonary hypertension on the United States. The investigators will also compare these
features to non-US sites.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients with sarcoidosis as defined by the ATS/WASOG statement
- Patients with pulmonary hypertension as confirmed by right heart catheterization
- Patients willing to provide written informed consent
Exclusion Criteria:
- Unwillingness to provide assurance that they will complete the follow up visits for
the study
Locations and Contacts
Robert P Baughman, MD, Phone: 513-584-5225, Email: bob.baughman@uc.edu
University of Cincinnati, Cincinnati, Ohio 45267, United States; Recruiting Rebecca Ingledue, Phone: 513-584-6252, Email: ingledra@ucmail.uc.edu Robert P Baughman, MD, Principal Investigator Peter Engel, MD, Sub-Investigator
Additional Information
Starting date: November 2011
Last updated: January 26, 2015
|